The Committee on Energy and Commerce's official website announced on September 10th that the Subcommittee on Health, a subcommittee of the committee, will hold a hearing on Tuesday, September 10, 2024 at 10:00 am Eastern Time in the John D. Dingell Conference Room at room 2123 of the Rayburn House Office Building. The theme of the hearing will be "Assessing the FDA's Human Food and Tobacco Program.
According to a hearing notice released by the committee on September 3, Chairman of the House Energy and Commerce Committee Cathy McMorris Rodgers and Chairman of the Health Subcommittee Brett Guthrie stated that...
This hearing will give our members the opportunity to hear from the head of the human food project and the head of the tobacco center, to understand how the FDA is helping adult smokers quit, preventing illegal products from reaching children, and ensuring the safety of the food supply.
The committee will hear testimonies from James "Jim" Jones, Deputy Commissioner for Foods at the US Food and Drug Administration (FDA), and Brian King, Director of the Center for Tobacco Products at the FDA.
In addition to hearing testimony, the hearing will also discuss a series of legislative proposals, including the Tobacco User Fee Modernization Act of 2024 (H.R. 9425).
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
